Top

Published in:

01-01-2009 | Letter to the Editors

Waiting for combined treatment with RAS inhibitors in children with primary glomerulonephritis

Author: Marco Zaffanello

Published in: Pediatric Nephrology | Issue 1/2009

Excerpt

Therapy with renin angiotensin system (RAS) inhibitors allows reno-protection in patients with glomerulonephritis (GN). Both angiotensin converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) are considered to be the drugs of first choice to improve kidney survival in adults with proteinuric nephropathy. Our knowledge of and interest in these drugs has increased in recent years, as has the number of review articles and publications on the topic. …

Nguyen T, Toto RD (2008) Slowing chronic kidney disease progression: results of prospective clinical trials in adults. Pediatr Nephrol 23:1409–1422CrossRef

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD (2006) Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 48:8–20CrossRef

Catapano F, Chiodini P, Nicola LD, Minutolo R, Zamboli P, Gallo C, Conte G (2008) Antiproteinuric response to dual blockade of the renin–angiotensin system in primary glomerulonephritis: meta-analysis and metaregression. Am J Kidney Dis doi:https://doi.org/10.1053/j.ajkd.2008.03.008 CrossRef

Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T (2007) IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18:1880–1888CrossRef

Borges FF, Shiraichi L, da Silva MP, Nishimoto EI, Nogueira PC (2007) Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome? Pediatr Nephrol 22:1309–1313CrossRef

Zaffanello M, Franchini M, Fanos V (2008) New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy. Pharmacotherapy 28:125–130CrossRef

Simonetti GD, von Vigier RO, Konrad M, Rizzi M, Fossali E, Bianchetti MG (2006) Candesartan cilexetil in children with hypertension or proteinuria: preliminary data. Pediatr Nephrol 21:1480–1482CrossRef

Litwin M, Grenda R, Sladowska J, Antoniewicz J (2006) Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol 21:1716–1722CrossRef

Wühl E, Schaefer F (2008) Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol 23:705–716CrossRef

Title: Waiting for combined treatment with RAS inhibitors in children with primary glomerulonephritis
Author: Marco Zaffanello
Publication date: 01-01-2009
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 1/2009
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-008-0936-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Waiting for combined treatment with RAS inhibitors in children with primary glomerulonephritis

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2009

Salt restriction in kidney disease—a missed therapeutic opportunity?

Methylated arginine derivatives in children and adolescents with chronic kidney disease

Recurrent lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin

Urinary vitamin A excretion in very low birth weight infants

Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis

Ambulatory blood pressure monitoring in healthy children with parental hypertension